Advancing Single Cell Proteomics Together at ESCP 2026

Join us for the Bruker eXceed Symposium on September 1, 2026, from 15:15 to 17:30 CEST at the IMP Lecture Hall, Vienna Biocenter. Learn from our timsTOF users in the fields of high-sensitivity and high-complexity cutting-edge proteomics applications to discover more, know more, and decide with confidence.

Expect practical insights, real-world data, and open discussion around:

• Reproducibility across laboratories and workflows
• Sensitivity improvements from single cell to ultra-low abundance detection
• Biological applications from microorganisms to complex systems
• Latest product developments and application advances from Bruker

Agenda Highlights

• Welcome & Latest Product News
  Christoph Krisp, Ph.D., Bruker Daltonics, Bremen, Germany
• How Reproducible Are Current Single-Cell Proteomics Workflows?
  Claudia Ctortecka, Ph.D., Amsterdam Cancer Research Center, Amsterdam, Netherlands
• Resolving Proteomic Diversity in Thermophilic Microorganisms at Single-Cell Resolution
  Sunu Lama and Francis Onyeka Offor, CNRS, University of Strasbourg,Strasbourg, France
• Pushing the Limits of Sensitivity Across Biological Scales
  David Gómez Varela, Ph.D., University of Vienna, Vienna, Austria

This symposium is designed for proteomics researchers who want to better understand how to generate reliable data at low sample input, improve sensitivity, and translate single-cell workflows into meaningful biological insights.

Event Details Bruker eXceed at ESCP

Date
September 1, 2026

Time
15:15 – 17:30 CEST

Location
IMP Lecture Hall
Research Institute of Molecular Pathology (IMP)
Campus Vienna Biocenter 1
1030 Vienna, Austria

As you are certainly aware, special compliance regulations apply to public officials* and healthcare professionals** with regard to the event we are planning. If you accept our invitation, we will therefore assume that you will observe the compliance regulations that apply to you and that you have the necessary employer approval.

* Government Official means according the Bruker policies any of the following: any officer, employee or representative of a government (national, regional or local) entity, or any public agency, public authority, department or instrumentality thereof, regardless of their rank or title (e.g. a regulatory official or government inspector); any person working for or advising a government-owned or government-controlled enterprise (e.g. a professor at a government-owned university, or a purchaser at a government-owned hospital); any person working for or advising a national or international non-governmental organization (e.g. an employee of the Red Cross or The World Bank); any person performing a public function or providing a public service, even if that person works for a nongovernmental institution (e.g. private security personnel working in public functions); any person hired to review or accept bids for a government agency; any person with the responsibility to allocate or expend government funds; any person in a public law function, civil servant, judge or military personnel; any person acting for a political party, including party officials, candidates or individuals holding a position in a political party office; members of royal families; or immediate family members of any of the persons listed above. An immediate family member is a grandparent, parent, spouse, significant other, child, or sibling.

** A Healthcare Professional (HCP) is in accordance with the Bruker policies any physician, dentist, nurse, pharmacist or other individual who may prescribe, administer, purchase, dispense, recommend, or supply medical products or treatments or pharmaceutical products. In many cases, Bruker interacts with HCPs who work for state-owned hospitals (e.g. as medical scientists). These individuals will be classified as both HCPs and Government Officials.